Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.57
Price to sales ratio
12.21

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3878
GUTS
Fractyl Health, Inc. - Common Stock
0.74 USD0.00%+7.25%0.00%-25.25%117.79 M USD
3891
NAUT
Nautilus Biotechnology, Inc. - Common Stock
0.90 USD-4.26%-2.17%-25.62%+30.43%114.53 M USD
3900
SEER
Seer, Inc. - Class A Common Stock
2.01 USD-0.50%0.00%+1.01%-0.99%111.30 M USD
3912
ONCY
Oncolytics Biotech Inc. - Common Stock
0.85 USD-1.16%+6.25%+8.97%-21.30%108.38 M USD

Frequently asked questions about Coya Therapeutics, Inc. Common Stock

What is the Coya Therapeutics, Inc. Common Stock stock price today?

The current price of Coya Therapeutics, Inc. Common Stock (COYA) is 4.86. Over the past 24 hours, the stock has changed by -0.21%. Follow the COYA chart for real-time price dynamics.

What is the stock ticker of Coya Therapeutics, Inc. Common Stock?

Coya Therapeutics, Inc. Common Stock trades under the ticker COYA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Coya Therapeutics, Inc. Common Stock stock going up?

COYA has changed by -0.82% over the last week, +21.50% over the last month, and -28.11% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Coya Therapeutics, Inc. Common Stock?

Coya Therapeutics, Inc. Common Stock currently has a market capitalization of 114.01 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were Coya Therapeutics, Inc. Common Stock earnings last quarter?

Last quarter, Coya Therapeutics, Inc. Common Stock reported earnings of -0.28 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Coya Therapeutics, Inc. Common Stock revenue for the last quarter?

Coya Therapeutics, Inc. Common Stock reported quarterly revenue of 243.75 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was Coya Therapeutics, Inc. Common Stock net income for the last quarter?

Coya Therapeutics, Inc. Common Stock reported net income of -6.64 M for the last quarter. The previous quarter showed -7.21 M, which means net income changed by +7.89%.

How many employees does Coya Therapeutics, Inc. Common Stock have?

As of the latest available data, Coya Therapeutics, Inc. Common Stock has 8 employees. Workforce size can provide additional context about the company's scale and operations.

What is Coya Therapeutics, Inc. Common Stock EBITDA?

Coya Therapeutics, Inc. Common Stock EBITDA is -7.04 M, and its EBITDA margin is -2 889.98%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Coya Therapeutics, Inc. Common Stock stock?

You can buy Coya Therapeutics, Inc. Common Stock (COYA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Coya Therapeutics, Inc. Common Stock stock?

Investing in Coya Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the COYA chart and related analysis on metatrader.com as part of your research.

News